NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 60 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $9,522,060 | +12.4% | 6,040,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $8,474,000 | +27.6% | 6,040,000 | +19.8% | 0.00% | 0.0% |
Q2 2022 | $6,640,000 | +0.6% | 5,040,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $6,602,000 | +5.1% | 5,040,000 | 0.0% | 0.00% | – |
Q4 2021 | $6,284,000 | -6.0% | 5,040,000 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $6,682,000 | -17.3% | 5,040,000 | -16.6% | 0.00% | 0.0% |
Q2 2021 | $8,075,000 | -0.6% | 6,040,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $8,120,000 | -2.6% | 6,040,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $8,334,000 | -15.7% | 6,040,000 | -16.0% | 0.00% | 0.0% |
Q3 2020 | $9,886,000 | -21.7% | 7,190,000 | -5.3% | 0.00% | 0.0% |
Q2 2020 | $12,620,000 | +29.7% | 7,590,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $9,727,000 | -29.5% | 7,590,000 | -15.8% | 0.00% | -50.0% |
Q4 2019 | $13,805,000 | +17.0% | 9,015,000 | +4.6% | 0.00% | +100.0% |
Q3 2019 | $11,796,000 | -15.9% | 8,615,000 | -19.4% | 0.00% | -50.0% |
Q2 2019 | $14,025,000 | -2.9% | 10,690,000 | -0.0% | 0.00% | 0.0% |
Q1 2019 | $14,449,000 | +97.4% | 10,692,000 | +74.4% | 0.00% | +100.0% |
Q4 2018 | $7,318,000 | -39.8% | 6,130,000 | -14.0% | 0.00% | 0.0% |
Q3 2018 | $12,154,000 | – | 7,130,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TENOR CAPITAL MANAGEMENT Co., L.P. | 45,447,000 | $60,497,000 | 1.31% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,366,000 | $5,924,000 | 0.54% |
Aequim Alternative Investments LP | 7,609,000 | $10,088,000 | 0.43% |
MACKAY SHIELDS LLC | 27,806,000 | $37,405,000 | 0.35% |
Weiss Asset Management LP | 10,000,000 | $13,290,000 | 0.33% |
WOLVERINE ASSET MANAGEMENT LLC | 13,230,000 | $17,541,000 | 0.13% |
Polar Asset Management Partners Inc. | 7,500,000 | $9,942,000 | 0.10% |
LORD, ABBETT & CO. LLC | 22,141,000 | $29,732,000 | 0.07% |
Calamos Advisors LLC | 7,500,000 | $9,967,000 | 0.05% |
D. E. Shaw & Co., Inc. | 39,270,000 | $52,046,000 | 0.04% |